Specify a stock or a cryptocurrency in the search bar to get a summary
iZafe Group AB Series B
IZAFE-BiZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally. The company has a collaboration with Zafe Care Systems AB and Sensorem AB. The company was formerly known as MediRätt AB (publ) and changed its name to iZafe Group AB (publ) in May 2019. The company was incorporated in 2008 and is headquartered in Stockholm, Sweden. Address: David Bagares Gata 3, Stockholm, Sweden, 111 38
Analytics
WallStreet Target Price
3.18 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures IZAFE-B
Dividend Analytics IZAFE-B
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IZAFE-B
Stock Valuation IZAFE-B
Financials IZAFE-B
Results | 2019 | Dynamics |